A61K 31/4406
Only substituted in position 3
Official title: only substituted in position 3, e.g. zimeldine (nicotinic acid A61K31/455)
A61K31/4406 (Only substituted in position 3) appears on 558 US grants and 938 published applications in this corpus.
Search patents in A61K- Granted patents
- 558
- Published applications
- 938
- Assignees
- 516
- Inventors
- 2,126
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1994 | 1 | 0 |
| 1995 | 2 | 0 |
| 1996 | 3 | 0 |
| 1997 | 17 | 0 |
| 1998 | 14 | 0 |
| 1999 | 8 | 0 |
| 2000 | 17 | 0 |
| 2001 | 14 | 2 |
| 2002 | 16 | 6 |
| 2003 | 8 | 18 |
| 2004 | 4 | 19 |
| 2005 | 4 | 15 |
| 2006 | 8 | 25 |
| 2007 | 6 | 15 |
| 2008 | 4 | 29 |
| 2009 | 7 | 25 |
| 2010 | 5 | 29 |
| 2011 | 11 | 34 |
| 2012 | 11 | 34 |
| 2013 | 24 | 32 |
| 2014 | 23 | 57 |
| 2015 | 31 | 58 |
| 2016 | 45 | 57 |
| 2017 | 45 | 69 |
| 2018 | 32 | 55 |
| 2019 | 38 | 54 |
| 2020 | 33 | 46 |
| 2021 | 26 | 55 |
| 2022 | 25 | 45 |
| 2023 | 27 | 52 |
| 2024 | 14 | 42 |
| 2025 | 21 | 34 |
| 2026 | 14 | 31 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Small molecule inhibitors of viral replication6 Oct 2026US 12,751,963 B2The Trustees of Princeton University
- Arylsulfonamides as orexin receptor agonists8 Sep 2026US 12,729,178 B2Research Triangle Institute
- Small molecule inhibitors of TLR2 signaling16 Jun 2026US 12,653,800 B2University of Maryland, Baltimore
- Terpenoid derivatives, pharmaceutical preparations containing these derivatives and their use in neuroprotection26 May 2026US 12,636,299 B2Univerzita Palackeho V Olomouci
- Fatty acid amide hydrolase (FAAH) cleavable prodrugs of thyromimetics and combination with peripherally restricted FAAH inhibitors26 May 2026US 12,637,413 B2Autobahn Therapeutics, Inc.
- Composition for removing and inhibiting senescent cells, and uses thereof8 Oct 2026US 2026/0306460 A1Lifeceutix Co., Ltd.
- Novel carboxamide derivatives8 Oct 2026US 2026/0308149 A1Angelini Pharma S.P.A.
- Drug for treating locally advanced unresectable or metastatic colorectal cancer and use thereof1 Oct 2026US 2026/0294882 A1Shenzhen Chipscreen Biosciences Co., Ltd.
- Highly water soluble schiff base prodrugs of benzaldehyde allosteric modulators3 Sep 2026US 2026/0256752 A1Illexcor Holdings, LLC
- Novel sulfanone derivative or pharmaceutically acceptable salt thereof, and use thereof27 Aug 2026US 2026/0248772 A1Korea Institute of Science and Technology
Most cited
By later US patents
- Pharmaceutical compositions for prevention and treatment of ulcerative colitis205US 5,604,231 A1997
- Styryl-substituted pyridyl compounds which inhibit EGF receptor tyrosine kinase174US 5,302,606 ARhone-Poulenc Rorer Pharmaceuticals Inc. · 1994
- Urologic irrigation solution and method for inhibition of pain, inflammation and spasm152US 5,858,017 AOmeros Medical Systems, Inc. · 1999
- Arthroscopic irrigation solution and method for inhibition of pain and inflammation140US 5,860,950 AOmeros Medical Systems, Inc. · 1999
- Vascular irrigation solution and method for inhibition of pain, inflammation, spasm and restenosis118US 5,800,385 AOmeros Medical Systems, Inc. · 1998